Evidence map›Paper›PMID 30008608›Full record

ArticleInternational journal of medical sciences2018

Polydatin, Natural Precursor of Resveratrol, Promotes Osteogenic Differentiation of Mesenchymal Stem Cells.

Adriana Di Benedetto, Francesca Posa, Salvatore De Maria, Giampietro Ravagnan, Andrea Ballini, Chiara Porro, Teresa Trotta, Maria Grano, Lorenzo Lo Muzio, Giorgio Mori

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Drug design, development and therapy · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Calycosin-7-O-β-Glucoside Isolated fromInternational journal of molecular sciences · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Adriana Di BenedettoDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Francesca PosaDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Salvatore De MariaGlures srl. Unità Operativa di Napoli, spin off accademico dell'Università di Venezia Cà Foscari, Italy.
Giampietro RavagnanGlures srl. Unità Operativa di Napoli, spin off accademico dell'Università di Venezia Cà Foscari, Italy.
Andrea BalliniDepartment of Basic Medical Sciences, Neurosciences and Organs of Senses, University of Bari, Bari, Italy.
Chiara PorroDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Teresa TrottaDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Maria GranoDepartment of Emergency and Organ Transplantation, Section of Human Anatomy and Histology, University of Bari, Bari, Italy.
Lorenzo Lo MuzioDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Giorgio MoriDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
University of Foggia · ITCa' Foscari University of Venice · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone loss and fractures are consequences of aging, diseases or traumas. Furthermore the increased number of aged people, due to the rise of life expectancy, needs more strategies to limit the bone loss and regenerate the lost tissue, ameliorating the life quality of patients. A great interest for non-pharmacological therapies based on natural compounds is emerging and focusing on the oligostilbene Polydatin, present in many kinds of fruits and vegetables, when resveratrol particularly in red wines. These molecules have been extensively studied due to their antioxidant and anti-inflammatory effects, showing more recently Resveratrol the ability to enhance osteogenic differentiation and bone formation. However, the clinical applications of Resveratrol are limited due to its low bioavailability and rapid metabolism, while its natural glycosilated precursor Polydatin shows better metabolic stability and major abundance in fresh fruits and vegetables. Nevertheless the role of Polydatin on osteogenic differentiation is still unexplored. Mesenchymal stem cells (MSCs) from dental tissues, such as dental bud stem cells (DBSCs), are able to differentiate toward osteogenic lineage: thus we investigated how Resveratrol and Polydatin influence the differentiation of DBSCs, eventually affecting bone formation. Our results showed that Polydatin increases MSCs osteogenic differentiation sharing similar properties with Resveratrol. These results encourage to deepen the effects of this molecule on bone health and its associated mechanisms of action, wishing for the future a successful use in bone loss prevention and therapy.

Indexed as

Cell DifferentiationCells, CulturedChildGlucosidesHumansMaleMesenchymal Stem CellsOsteogenesisResveratrolStilbenesGlucosidespolydatinResveratrolStilbenesbone health.Mesenchymal Stem Cells (MSCs)osteogenic differentiationphytochemicalsPolydatinResveratrol

Identifiers

PMID30008608
PMCPMC6036093
OpenAlexW2808476104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.